for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

KYORIN Holdings, Inc.

4569.T

Latest Trade

1,785.00JPY

Change

-35.00(-1.92%)

Volume

138,200

Today's Range

1,777.00

 - 

1,803.00

52 Week Range

1,663.00

 - 

2,234.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,820.00
Open
1,801.00
Volume
138,200
3M AVG Volume
3.08
Today's High
1,803.00
Today's Low
1,777.00
52 Week High
2,234.00
52 Week Low
1,663.00
Shares Out (MIL)
57.30
Market Cap (MIL)
117,586.40
Forward P/E
16.63
Dividend (Yield %)
4.12

Next Event

Q1 2022 Kyorin Holdings Inc Earnings Release

Latest Developments

More

Kyorin Holdings Inc - Director Hiromi Watanabe To Become President Effective June 21

Kyorin Holdings to retire treasury shares

Kyorin Holdings to repurchase up to 24.1 pct shares for 44.35 bln yen

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About KYORIN Holdings, Inc.

KYORIN Holdings, Inc. is a Japan-based holding company mainly engaged in the manufacturing and sales of pharmaceuticals. The Company operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. It also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Industry

Biotechnology & Drugs

Contact Info

15/16F, Ochanomizu Sorashiti

4-6, Kanda Surugadai

CHIYODA-KU, TKY

101-8311

Japan

+81.3.35254700

http://www.kyorin-gr.co.jp

Executive Leadership

Minoru Hogawa

Chairman of the Board, Chairman of Subsidiary, Representative Director

Yutaka Ogihara

President, Representative Director

Yo Ito

Senior Executive Officer, Senior Director of Group Accounting & Finance

Michio Ohnota

President of Subsidiary, Director

Shigeru Ogihara

Senior Managing Director, President of Subsidiary

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2019

0.1K

2020

0.1K

2021

0.1K

2022(E)

0.1K
EPS (JPY)

2019

104.680

2020

107.350

2021

106.990

2022(E)

108.800
Price To Earnings (TTM)
17.01
Price To Sales (TTM)
1.14
Price To Book (MRQ)
0.84
Price To Cash Flow (TTM)
12.13
Total Debt To Equity (MRQ)
17.73
LT Debt To Equity (MRQ)
9.18
Return on Investment (TTM)
4.39
Return on Equity (TTM)
3.62

Latest News

Latest News

Japan shares slide for fourth day as pandemic fears grow

Japan's benchmark Nikkei fell for a fourth day on Thursday, as investors were spooked by the rapid expansion of the global coronavirus outbreak, with the United States reporting its first possible community spread.

Japanese shares fall for fourth day as pandemic fears rise

Japan's Nikkei share average fell for a fourth day on Thursday as investors were spooked by the rapid expansion of the global coronavirus outbreak, with the United States reporting its first possible community spread.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up